IgA nephropathy is a kidney condition, leading to kidney failure for many of those who are affected. About 10-20% of patients require dialysis or a kidney transplant within 10 years, and 30-40% within 20 years, from their disease onset. This long time between diagnosis and kidney failure makes it difficult to establish the most effective and safest treatment.
In August 2015, Marinella Ruospo and her colleagues from Bari, Italy updated their Cochrane Review of immunosuppressive therapies and she tells us what they have found in this Evidence pod.
Listen to the podcast: Immunosuppressive agents for treating IgA nephropathy